Healthcare -
Biotechnology - NASDAQ - US
$ 0.3171
-13.2 %
$ 39.5 M
Market Cap
-0.65
P/E
MRSN - REVENUE
Revenue MRSN - Mersana Therapeutics, Inc.
40.5 M
LAST VALUE
23.43%
2 YEAR CAGR
-0.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR